LIVE ONLINE COURSE

Introduction to
Biopharmaceuticals

A practical introduction to how complex biological medicines are developed, manufactured and controlled—from the choice of expression system to GMP production and analytical characterisation.

Date and time: November 4th, 2026

09:00 - 13.00 CET

Online · Live session

Trainer: Dr. Leonardo Sibilio

Includes a certificate of attendance and course materials. Final details will be confirmed with registration.

Early Bird available until October 14th, 2026

Why this course matters

Biopharmaceuticals are transforming healthcare, but they are also fundamentally different from conventional small-molecule drugs. Their quality is shaped by living systems, complex processes and tightly connected manufacturing and analytical decisions.

This course gives participants a coherent view of the full journey—from cell line and process development through technology transfer, GMP manufacturing and product characterisation—so that individual tasks make sense within the wider product lifecycle.

What you will learn

By the end of the course, participants will have a clearer understanding of:

  • How expression systems and cell lines are selected for different biopharmaceutical products

  • How upstream and downstream process development creates robust, scalable manufacturing

  • How technology transfer connects development laboratories with GMP production

  • How monoclonal antibodies, recombinant proteins, viral vectors, mRNA and other advanced products are manufactured

  • How quality control and analytical characterisation demonstrate identity, purity, potency and safety

  • How scientific, process and regulatory decisions interact across the product lifecycle

The focus is practical: connecting biological science with the realities of industrial development, manufacturing and control.

What is included

  • Live online training with Dr. Leonardo Sibilio

  • Structured learning across the complete biopharmaceutical lifecycle

  • Real-world examples from monoclonal antibodies, recombinant proteins and viral vectors

  • Course materials for reference after the session

  • Certificate of attendance

Early Bird available until October 14th, 2026

Who this course is for

This course is especially relevant for professionals working in or around:

  • Process Development and MSAT

  • GMP Manufacturing

  • Quality Assurance and Quality Control

  • Analytical Development

  • R&D and Technology Transfer

  • Regulatory Affairs

  • Biotechnology and pharmaceutical operations

  • Professionals moving from academia into industry

It is particularly useful for professionals who want to understand how their specialist role connects with the decisions made before and after their own stage of the process.

Why this matters for your work

Biopharmaceutical development is a chain of interdependent decisions. A cell line choice affects the process; the process shapes the product; analytical methods determine how its quality is understood and controlled.

A strong overview helps teams communicate across functions, anticipate downstream consequences and make better-informed decisions in regulated environments.

€349 regular price
Available until October 14th, 2026

About the trainer

Dr. Leonardo Sibilio

Biopharma professional and Trainer

Leonardo Sibilio is a biopharma professional and Manager with more than 20 years of experience in Process Development, GMP Manufacturing and R&D. His expertise spans monoclonal antibodies, recombinant proteins and viral vectors, with experience at Menarini Biotech, IBI-Lorenzini and ReiThera. He brings an end-to-end industry perspective that connects scientific development with the practical requirements of regulated manufacturing.

Frequently asked questions

Do I need previous auditing experience?

No. The course builds a structured foundation while remaining useful to professionals who already work in one part of the biopharmaceutical lifecycle.

Is the course online?

Yes. It is designed as a live online course, with the final schedule to be confirmed.

What topics are covered?

Expression systems, cell line development, biopharmaceutical product types, process development, technology transfer, GMP manufacturing, quality control and analytical characterisation.

Will I receive a certificate?

A certificate of attendance is planned. Final attendance requirements will be confirmed with the course schedule.

Can companies register more than one participant?

Yes. Companies can request multiple seats and tailored training options from Biotech Academy in Rome.

What happen after registration?

You will receive confirmation and the practical information needed to join the live online session.

Understand the full biopharmaceutical journey

Build the cross-functional perspective needed to contribute with more clarity—from development choices to GMP manufacturing and product control.

Save €100 until October 14th 2026 · Regular price €349

Registered Office

Nexantia Biotherapeutics S.r.l. 
Viale di Trastevere 141, 00153 Rome Italy

P.IVA:  IT17204271005

SDI: 5RUO82D